Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Resistant hypertension--its identification and epidemiology.

Sarafidis PA, Georgianos P, Bakris GL.

Nat Rev Nephrol. 2013 Jan;9(1):51-8. doi: 10.1038/nrneph.2012.260. Epub 2012 Nov 20. Review. Erratum in: Nat Rev Nephrol. 2013 Sep;9(9):492.

PMID:
23165303
2.

Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population.

Sarafidis PA, Georgianos PI, Zebekakis PE.

Semin Nephrol. 2014;34(5):483-91. doi: 10.1016/j.semnephrol.2014.08.001. Review.

PMID:
25416656
3.

Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system.

Sim JJ, Bhandari SK, Shi J, Liu IL, Calhoun DA, McGlynn EA, Kalantar-Zadeh K, Jacobsen SJ.

Mayo Clin Proc. 2013 Oct;88(10):1099-107. doi: 10.1016/j.mayocp.2013.06.017.

4.

Resistant hypertension: medical management and alternative therapies.

Ghofrani H, Weaver FA, Nadim MK.

Cardiol Clin. 2015 Feb;33(1):75-87. doi: 10.1016/j.ccl.2014.09.003. Review.

PMID:
25439332
5.

Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.

Brambilla G, Bombelli M, Seravalle G, Cifkova R, Laurent S, Narkiewicz K, Facchetti R, Redon J, Mancia G, Grassi G.

J Hypertens. 2013 Oct;31(10):2018-24. doi: 10.1097/HJH.0b013e328363823f.

PMID:
23838657
6.

What is the prevalence of resistant hypertension in the United States?

Roberie DR, Elliott WJ.

Curr Opin Cardiol. 2012 Jul;27(4):386-91. doi: 10.1097/HCO.0b013e328353ad6e. Review.

PMID:
22596184
7.

Clinical management of resistant hypertension: practical recommendations from the Italian Society of Hypertension (SIIA).

Veglio F, Grassi G, Mancia G, Volpe M; Italian Society of Hypertension..

High Blood Press Cardiovasc Prev. 2013 Dec;20(4):251-6. doi: 10.1007/s40292-013-0022-3. Epub 2013 Aug 15.

PMID:
23949949
8.

Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients.

De Nicola L, Gabbai FB, Agarwal R, Chiodini P, Borrelli S, Bellizzi V, Nappi F, Conte G, Minutolo R.

J Am Coll Cardiol. 2013 Jun 18;61(24):2461-7. doi: 10.1016/j.jacc.2012.12.061. Epub 2013 Apr 23.

9.

Epidemiology of resistant hypertension.

Sarafidis PA.

J Clin Hypertens (Greenwich). 2011 Jul;13(7):523-8. doi: 10.1111/j.1751-7176.2011.00445.x. Epub 2011 Mar 28. Review.

10.

Ambulatory blood pressure and adherence monitoring: diagnosing pseudoresistant hypertension.

Burnier M, Wuerzner G.

Semin Nephrol. 2014;34(5):498-505. doi: 10.1016/j.semnephrol.2014.08.003. Review.

PMID:
25416658
11.

Resistant hypertension: an overview of evaluation and treatment.

Sarafidis PA, Bakris GL.

J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. doi: 10.1016/j.jacc.2008.08.036. Review.

12.

Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.

Veglio F, Rabbia F, Riva P, Martini G, Genova GC, Milan A, Paglieri C, Carra R, Chiandussi L.

Clin Exp Hypertens. 2001 Apr;23(3):203-11.

PMID:
11339687
13.

[Resistant hypertension].

Bendersky M.

Rev Fac Cien Med Univ Nac Cordoba. 2012;69(3):156-9. Review. Spanish.

PMID:
23286578
14.

Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance?

Lazaridis AA, Sarafidis PA, Ruilope LM.

Curr Hypertens Rep. 2015 Oct;17(10):78. doi: 10.1007/s11906-015-0590-9. Review.

PMID:
26277726
15.

HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.

Seravalle G, Koylan N, Nalbantgil I, Caglar N, Quarti-Trevano F, Makel W, Grassi G, Fici F.

High Blood Press Cardiovasc Prev. 2015 Jun;22(2):165-72. doi: 10.1007/s40292-015-0091-6. Epub 2015 Apr 22.

PMID:
25900022
16.

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.

Rao MV, Qiu Y, Wang C, Bakris G.

Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S30-7. doi: 10.1053/j.ajkd.2007.12.012.

PMID:
18359406
17.

The prevalence, incidence, prognosis, and associated conditions of resistant hypertension.

Vega J, Bisognano JD.

Semin Nephrol. 2014 May;34(3):247-56. doi: 10.1016/j.semnephrol.2014.04.002. Epub 2014 Apr 18. Review.

PMID:
25016397
18.

Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.

de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Oliveras A, Ruilope LM.

Hypertension. 2011 May;57(5):898-902. doi: 10.1161/HYPERTENSIONAHA.110.168948. Epub 2011 Mar 28.

19.

Apparent and true resistant hypertension: definition, prevalence and outcomes.

Judd E, Calhoun DA.

J Hum Hypertens. 2014 Aug;28(8):463-8. doi: 10.1038/jhh.2013.140. Epub 2014 Jan 16. Review.

20.

Incidence and prognosis of resistant hypertension in hypertensive patients.

Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O'Connor PJ, Selby JV, Ho PM.

Circulation. 2012 Apr 3;125(13):1635-42. doi: 10.1161/CIRCULATIONAHA.111.068064. Epub 2012 Feb 29.

Supplemental Content

Support Center